Dana-Farber Cancer Institute
@danafarber.bsky.social
A leading center for expert, compassionate cancer care and advanced research.
Appts: 877-442-3324 | http://dana-farber.org
Appts: 877-442-3324 | http://dana-farber.org
We’re proud to be included in @forbes.com's 2026 Best Large Employer list. This recognition, based on employee sentiment, reflects our commitment to fostering a collaborative workplace where employees feel valued, supported, and empowered for long-term growth.
View the list here: bit.ly/403x3ri
View the list here: bit.ly/403x3ri
Forbes 2026 America's Best Large Employers List
Forbes' list of America's Best Large Employers ranks the largest top companies to work for in 2026, featuring companies with the best benefits and best work-life balance.
bit.ly
February 13, 2026 at 5:30 PM
We’re proud to be included in @forbes.com's 2026 Best Large Employer list. This recognition, based on employee sentiment, reflects our commitment to fostering a collaborative workplace where employees feel valued, supported, and empowered for long-term growth.
View the list here: bit.ly/403x3ri
View the list here: bit.ly/403x3ri
Congratulations to Catherine Wu, MD, on being recognized by TIME in the TIME100 Health 2026 list. Read more: bit.ly/4kEx3ru
TIME100 Health: Catherine Wu
Find out why Catherine Wu is on the TIME100 Health 2026 list.
bit.ly
February 13, 2026 at 1:00 PM
Congratulations to Catherine Wu, MD, on being recognized by TIME in the TIME100 Health 2026 list. Read more: bit.ly/4kEx3ru
Dana-Farber-led research helped drive an @fda.gov label update for axicabtagene ciloleucel (Yescarta) that removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients. Learn more: bit.ly/4rjfgbU
Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma | Dana-Farber Cancer Institute
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system lymphoma, a rare and aggressive lymphoma of the brain and spinal cord. The change is expected to expand access to commercial CAR T-cell therapy for eligible patients with relapsed or refractory disease.
bit.ly
February 12, 2026 at 9:42 PM
Dana-Farber-led research helped drive an @fda.gov label update for axicabtagene ciloleucel (Yescarta) that removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients. Learn more: bit.ly/4rjfgbU
A historic moment.
Last week, we announced the largest single gift in our history through a transformational joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family.
Last week, we announced the largest single gift in our history through a transformational joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family.
February 11, 2026 at 9:45 PM
A historic moment.
Last week, we announced the largest single gift in our history through a transformational joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family.
Last week, we announced the largest single gift in our history through a transformational joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family.
Reposted by Dana-Farber Cancer Institute
The Center for Global Health at @danafarbernews.bsky.social is excited to launch the first colorectal cancer screening program in Central Asia, partnering with Uzbekistan's Ministry of Health and National Cancer Center.
Read more here: bit.ly/4bzLivg
Read more here: bit.ly/4bzLivg
February 10, 2026 at 1:15 PM
The Center for Global Health at @danafarbernews.bsky.social is excited to launch the first colorectal cancer screening program in Central Asia, partnering with Uzbekistan's Ministry of Health and National Cancer Center.
Read more here: bit.ly/4bzLivg
Read more here: bit.ly/4bzLivg
Reposted by Dana-Farber Cancer Institute
Dana-Farber developed one of the first clinical cancer genetics and prevention programs in the world and remains one of the largest centers of its kind, providing expert, long-term, comprehensive care for cancer patients, survivors, and people seeking risk assessment and prevention care.
February 10, 2026 at 3:25 PM
Dana-Farber developed one of the first clinical cancer genetics and prevention programs in the world and remains one of the largest centers of its kind, providing expert, long-term, comprehensive care for cancer patients, survivors, and people seeking risk assessment and prevention care.
We’re proud to announce a new strategic collaboration with OncoClinic to bring advanced and personalized oncology to Saudi Arabia. Learn more: bit.ly/4afscrT
February 9, 2026 at 4:25 PM
We’re proud to announce a new strategic collaboration with OncoClinic to bring advanced and personalized oncology to Saudi Arabia. Learn more: bit.ly/4afscrT
Reposted by Dana-Farber Cancer Institute
The @washingtonpost.com recognized @danafarber.bsky.social's Dr. Kimmie Ng for her work in young-onset colorectal cancer. Dr. Ng is part of the 'Post Next 50,' the newspaper's annual look at 50 people shaping society in 2026.
Read more here: bit.ly/4kqFWob
Read more here: bit.ly/4kqFWob
February 9, 2026 at 3:00 PM
The @washingtonpost.com recognized @danafarber.bsky.social's Dr. Kimmie Ng for her work in young-onset colorectal cancer. Dr. Ng is part of the 'Post Next 50,' the newspaper's annual look at 50 people shaping society in 2026.
Read more here: bit.ly/4kqFWob
Read more here: bit.ly/4kqFWob
Congratulations to Alice Shaw, MD, PhD, Kimberly Stegmaier, MD, and Matthew Vander Heiden, MD, PhD, on being elected as Fellows of the @theaacr.bsky.social Academy Class of 2026. Learn more: bit.ly/45KykqC
February 7, 2026 at 2:00 PM
Congratulations to Alice Shaw, MD, PhD, Kimberly Stegmaier, MD, and Matthew Vander Heiden, MD, PhD, on being elected as Fellows of the @theaacr.bsky.social Academy Class of 2026. Learn more: bit.ly/45KykqC
This week, we had the honor celebrating the largest single gift in our history: a transformative joint commitment from the Josh and Anita Bekenstein and Jonathan and Jeannie Lavine families to name and help build our future cancer hospital.
February 6, 2026 at 5:01 PM
This week, we had the honor celebrating the largest single gift in our history: a transformative joint commitment from the Josh and Anita Bekenstein and Jonathan and Jeannie Lavine families to name and help build our future cancer hospital.
Reposted by Dana-Farber Cancer Institute
ICYMI: Research by @danafarber.bsky.social's Vinayak Venkataraman, MD, in the Journal of Adolescent and Young Adult Oncology confirmed that #sarcoma and its treatment greatly disrupted the lives of #AYA patients – yet earlier introduction of support services may ease some challenges. bit.ly/3ZRpROT
February 6, 2026 at 3:30 PM
ICYMI: Research by @danafarber.bsky.social's Vinayak Venkataraman, MD, in the Journal of Adolescent and Young Adult Oncology confirmed that #sarcoma and its treatment greatly disrupted the lives of #AYA patients – yet earlier introduction of support services may ease some challenges. bit.ly/3ZRpROT
Reposted by Dana-Farber Cancer Institute
Join us on Tuesday, February 24 at 6PM ET in Cambridge, MA (or online) for a Broad Discovery Series talk with Heidi Greulich and Matthew Meyerson, “The story behind a new therapy for lung cancer patients.” Register: broadinstitute.swoogo.com/Discovery26
January 29, 2026 at 9:44 PM
Join us on Tuesday, February 24 at 6PM ET in Cambridge, MA (or online) for a Broad Discovery Series talk with Heidi Greulich and Matthew Meyerson, “The story behind a new therapy for lung cancer patients.” Register: broadinstitute.swoogo.com/Discovery26
Reposted by Dana-Farber Cancer Institute
At @danafarber.bsky.social, we are reimagining the future of cancer care. This #WorldCancerDay, we're taking time to reflect on all the ways your generous support has helped make a difference around the globe. 🌎
February 4, 2026 at 7:41 PM
At @danafarber.bsky.social, we are reimagining the future of cancer care. This #WorldCancerDay, we're taking time to reflect on all the ways your generous support has helped make a difference around the globe. 🌎
We are profoundly grateful to announce the largest single gift in our 78-year history through a new joint commitment from Josh and Anita Bekenstein and the Jonathan Lavine and Jeannie Lavine family.
February 4, 2026 at 5:31 PM
We are profoundly grateful to announce the largest single gift in our 78-year history through a new joint commitment from Josh and Anita Bekenstein and the Jonathan Lavine and Jeannie Lavine family.
Reposted by Dana-Farber Cancer Institute
Thank you to the Pan Mass Challenge community for their commitment to raising incredible funds for cancer care and research! This past weekend, riders, volunteers, sponsors, and donors came together to be a part of the PMC Winter Cycle at Fenway Park.
February 3, 2026 at 3:52 PM
Thank you to the Pan Mass Challenge community for their commitment to raising incredible funds for cancer care and research! This past weekend, riders, volunteers, sponsors, and donors came together to be a part of the PMC Winter Cycle at Fenway Park.
The 2026 Transatlantic Exchange in Oncology Conference, hosted by Dana-Farber and @gustaveroussy.fr, will take place in Boston on March 27. This year’s event, co-chaired by @drchoueiri.bsky.social, MD, will focus on Transatlantic Innovations in Cancer Drug Research.
Register here: bit.ly/4bs5q2n
Register here: bit.ly/4bs5q2n
February 1, 2026 at 2:45 PM
The 2026 Transatlantic Exchange in Oncology Conference, hosted by Dana-Farber and @gustaveroussy.fr, will take place in Boston on March 27. This year’s event, co-chaired by @drchoueiri.bsky.social, MD, will focus on Transatlantic Innovations in Cancer Drug Research.
Register here: bit.ly/4bs5q2n
Register here: bit.ly/4bs5q2n
Please join us in congratulating Anne Gross, PhD, RN, FAAN, who was recently named to Becker’s Hospital Review's CNOs to Know 2025. View the list here: bit.ly/4pUxpeh
274 hospital and health system CNOs to know | 2025
Explore the 274 hospital health system CNOs leading nursing strategy and innovation in patient care across U.S. healthcare organizations in 2025.
bit.ly
January 31, 2026 at 1:30 PM
Please join us in congratulating Anne Gross, PhD, RN, FAAN, who was recently named to Becker’s Hospital Review's CNOs to Know 2025. View the list here: bit.ly/4pUxpeh
Reposted by Dana-Farber Cancer Institute
Donations of whole blood and platelets are urgently needed at the Kraft Family Blood Donor Center b/c of the national shortage due to storms and flight disruptions. Make an appointment today to support patients from @danafarbernews.bsky.social and Brigham & Women’s Hospital: bit.ly/4a3ssu2
January 30, 2026 at 9:03 PM
Donations of whole blood and platelets are urgently needed at the Kraft Family Blood Donor Center b/c of the national shortage due to storms and flight disruptions. Make an appointment today to support patients from @danafarbernews.bsky.social and Brigham & Women’s Hospital: bit.ly/4a3ssu2
From personalized cancer vaccines to next-generation cell therapies, our researchers are driving breakthroughs that could change how cancer is treated, detected, and prevented.
Here are 10 breakthroughs giving us hope in 2026: bit.ly/4rm3UmV
Here are 10 breakthroughs giving us hope in 2026: bit.ly/4rm3UmV
Ten Cancer-Related Breakthroughs Giving Us Hope in 2026
Published: January 20, 2026Written by: Beth DoughertyCancer treatment has evolved dramatically in the first quarter of this century, but there is still much more to do to improve the lives of people with cancer. At Dana-Farber, research continues in the clinic and in the lab in efforts to continue to bring advancements in treatment and prevention for ... Read more
bit.ly
January 29, 2026 at 5:50 PM
From personalized cancer vaccines to next-generation cell therapies, our researchers are driving breakthroughs that could change how cancer is treated, detected, and prevented.
Here are 10 breakthroughs giving us hope in 2026: bit.ly/4rm3UmV
Here are 10 breakthroughs giving us hope in 2026: bit.ly/4rm3UmV
The list is out! More than 145 Dana-Farber affiliated faculty are recognized as 2026 Top Doctors by @bostonmagazine.bsky.social. Congratulations to all!
View the list here: bit.ly/49YcUaW
View the list here: bit.ly/49YcUaW
January 27, 2026 at 2:54 PM
The list is out! More than 145 Dana-Farber affiliated faculty are recognized as 2026 Top Doctors by @bostonmagazine.bsky.social. Congratulations to all!
View the list here: bit.ly/49YcUaW
View the list here: bit.ly/49YcUaW
We hope everyone is staying safe and warm this weekend. We will work to accommodate patients who may be delayed or need to reschedule. ❄️
January 25, 2026 at 9:30 PM
We hope everyone is staying safe and warm this weekend. We will work to accommodate patients who may be delayed or need to reschedule. ❄️
Please join us in congratulating Philip J. Kranzusch, PhD, on receiving the 2026 NAS Award in Molecular Biology. Kranzusch’s seminal work has reshaped our understanding of human innate immunity, revealing its evolutionary links to bacterial antiviral defense. Learn more: bit.ly/4roj0sj
January 25, 2026 at 2:00 PM
Please join us in congratulating Philip J. Kranzusch, PhD, on receiving the 2026 NAS Award in Molecular Biology. Kranzusch’s seminal work has reshaped our understanding of human innate immunity, revealing its evolutionary links to bacterial antiviral defense. Learn more: bit.ly/4roj0sj
Researchers in @vanallenlab.bsky.social developed an experimental AI-based oncologist’s assistant to explore how AI could support precision oncology. Early testing showed promising accuracy. The assistant is intended for research purposes, with additional study needed before clinical use.
Dana-Farber Researchers Create Experimental AI-based Oncologist’s Assistant
Published: January 15, 2026Updated: January 20, 2026Key Takeaways: Powered by large-language models that have been given a crash course in precision oncology, the AI-based oncologist’s assistant shows the potential for AI to help oncologists keep up with the fast pace of approvals of precision cancer medicines. More research is needed before such tools can be ... Read more
bit.ly
January 22, 2026 at 10:05 PM
Researchers in @vanallenlab.bsky.social developed an experimental AI-based oncologist’s assistant to explore how AI could support precision oncology. Early testing showed promising accuracy. The assistant is intended for research purposes, with additional study needed before clinical use.
Physicians, join our in-person CME "Topics in Gastrointestinal Oncology" on 2/7 for case-based guidance on managing GI cancers through expert-led discussions, interactive sessions, & practical problem-solving to enhance clinical competence. Register here: bit.ly/49Ad1ZS
Topics in Gastrointestinal Oncology | Harvard Medical School Professional, Corporate, and Continuing Education
Deliver up-to-date, case-based guidance on managing gastrointestinal cancers through expert-led discussions, interactive sessions, and practical problem-solving designed to enhance clinical competence.
bit.ly
January 16, 2026 at 4:45 PM
Physicians, join our in-person CME "Topics in Gastrointestinal Oncology" on 2/7 for case-based guidance on managing GI cancers through expert-led discussions, interactive sessions, & practical problem-solving to enhance clinical competence. Register here: bit.ly/49Ad1ZS
Lachelle Weeks, MD, PhD, treats patients with acute myeloid leukemia, one of the hardest blood cancers to treat. She believes survival rates can be improved not just with new treatments, but also by finding ways to prevent the disease before it starts.
Learn more: bit.ly/4sDXMb1
Learn more: bit.ly/4sDXMb1
January 14, 2026 at 5:05 PM
Lachelle Weeks, MD, PhD, treats patients with acute myeloid leukemia, one of the hardest blood cancers to treat. She believes survival rates can be improved not just with new treatments, but also by finding ways to prevent the disease before it starts.
Learn more: bit.ly/4sDXMb1
Learn more: bit.ly/4sDXMb1